|Bid||0.000 x 61000|
|Ask||0.000 x 40000|
|Day's Range||26.400 - 27.025|
|52 Week Range||26.400 - 50.330|
|PE Ratio (TTM)||377.79|
|Dividend & Yield||1.36 (3.75%)|
|1y Target Est||N/A|
Billionaires appear to have focused on drug stocks that were mired in debt in Q1.
The Vetr crowd on Thursday upgraded its rating for Teva Pharmaceutical Industries Limited (ADR) (NYSE: TEVA ) from 3.5 stars (Buy), issued 15 days ago, to 4.5 stars (Strong Buy). Crowd sentiment at the ...
Israel's largest firm is also searching for a chief financial officer in which three candidates are vying for the position.